Lymphoma

Showing NaN - NaN of 158

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Lymphoma, Myeloma Trial in Miami, Chicago, San Antonio (LLS Program)

Not yet recruiting
  • Leukemia
  • +4 more
  • LLS Program
  • Miami, Florida
  • +2 more
Feb 16, 2023

Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)

Completed
  • Solid Tumor
  • Lymphoma
  • MK-2118 (IT)
  • +2 more
  • La Jolla, California
  • +7 more
Jan 23, 2023

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Solid Tumors, Lymphoma Trial in Worldwide (ASTX660)

Active, not recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +68 more
Nov 18, 2022

Lymphoma Trial in United States (Ruxolitinib)

Recruiting
  • Lymphoma
  • Miami, Florida
  • +9 more
Oct 5, 2022

Lymphoma Trial in United States (biological, drug, radiation)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
Sep 23, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Collecting and Storing Tissue From Young Patients With Cancer

Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
Aug 4, 2022

Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +3 more
  • Greenbrae, California
  • +226 more
Mar 7, 2022

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (Durvalumab, Lenalidomide, Rituximab)

Active, not recruiting
  • Lymphoma
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Gilbert, Arizona
  • +53 more
Jan 25, 2022

Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)

Completed
  • Breast Cancer
  • Lymphoma
  • Los Angeles, California
  • +50 more
Dec 6, 2021

Non-hodgkin Lymphoma, Hodgkin Lymphoma, Lymphoma Trial in Chicago (Radiation - Dose Level 0, Radiation - Dose Level 1, Radiation

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • Radiation - Dose Level 0
  • +4 more
  • Chicago, Illinois
    University of Chicago
Dec 3, 2021

Lymphoma Trial in United States (ABVD, BEACOPP, radiation therapy)

Completed
  • Lymphoma
  • Saint Helena, California
  • +54 more
Nov 5, 2021

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
Oct 25, 2021

Lymphoma Trial in United States (rituximab, bendamustine HCl, cyclophosphamide)

Completed
  • Lymphoma
  • rituximab
  • +8 more
  • Duarte, California
  • +203 more
Oct 14, 2021

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021

Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • rituximab
  • +7 more
  • Duarte, California
  • +24 more
Aug 16, 2021

Lymphoma Trial in United States (carmustine, cytarabine, etoposide)

Active, not recruiting
  • Lymphoma
  • Anchorage, Alaska
  • +125 more
Aug 16, 2021

Lymphoma Trial in United States (biological, drug, radiation, procedure)

Completed
  • Lymphoma
  • Bleomycin Sulfate
  • +11 more
  • Tucson, Arizona
  • +94 more
Jun 10, 2021

Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in United States (fimepinostat, Rituximab, venetoclax)

Completed
  • Lymphoma
  • +10 more
  • Los Angeles, California
  • +10 more
May 5, 2021

Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Chicago (Fludarabine-Melphalan & Rabbit antithymocyte globulin

Completed
  • Leukemia
  • +3 more
  • Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG)
  • +4 more
  • Chicago, Illinois
    The University of Chicago
Jan 8, 2021